|Dr. Michael S. Perry DVM, Ph.D., FACVPT||CEO & Exec. Director||53.54k||N/A||59|
|Mr. Timothy Rooney||Chief Admin. Officer||N/A||N/A||N/A|
|Mr. Andrew Quick||Sr. VP of Clinical Devel.||N/A||N/A||N/A|
|Mr. Gabriel Mario Chiappini B.Bus, CA, GAICD, B.Com, ICAA, MAICD||Company Sec.||N/A||N/A||N/A|
|Mr. Adam Kelliher||Consultant||623.82k||N/A||N/A|
Avita Medical Limited, a medical device company, develops and distributes regenerative products for the treatment of a range of wounds, scars, and skin defects in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. Its patented and proprietary collection and application technology provides treatment solutions derived from a patient's own skin. The company's lead product, ReCell, is used in the treatment of various burns, plastic, reconstructive, and cosmetic procedures. It also offers ReGenerCell for chronic wounds and ReNovaCell for pigmentation. Avita Medical Limited is based in Valencia, California.
Avita Medical Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.